Overall tolerability of the treatment was good, with the most common side effect being nausea, particularly during treatment initiation or dose adjustments, while diarrhea was reported by 5% of patients, which was dose-dependent and easily managed
If you dont see a drop, repeat up to six more times until you do
Because retatrutide is an unlicensed investigational medicine, participants in clinical trials should follow the specific training and instructions for use (IFU) provided by their trial team and the device manufacturer
Our expert providers will assess your overall health to determine if you qualify for a GLP-1 medication
Bioconjug Che
GLP-1s are not a shortcut theyre a scientific breakthrough that demands care, precision, and context, said Dr